1 / 8

Nivolumab Global Market Report 2024

The nivolumab market size has grown rapidly in recent years. It will grow from $1.47 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%.

SushmithaTBRC
Download Presentation

Nivolumab Global Market Report 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nivolumab Global Market Report 2024 Global Forecast 2024 – 2033 Market Size, Drivers, And Trends Top Market Research Firm 2023! We are honored to be listed as a top company at the forefront of research, by the Business Management Review © The Business Research Company. All Rights Reserved.

  2. Nivolumab Market Segments The Business Research Company segments the nivolumab market report as: Injection 4mL, Injection 10mL By Type By Route Of Administration Intravenous, Other Routes Of Administration Melanoma, Non-small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma, Classical Hodgkin Lymphoma (CHL), Squamous Cell Carcinoma Of The Head And Neck (SCCHN), Renal Cell Carcinoma (RCC), Other Applications By Application By End-User Clinic, Hospital, Other End-Users © The Business Research Company. All Rights Reserved.

  3. Market Statistics The global Nivolumab market size grew from $1.47 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%.The Nivolumab market size is expected to grow to $2.81 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%. $2.81 B $1.69 B $1.47 B Click Here To Get A Sample Report © The Business Research Company. All Rights Reserved.

  4. Key Market Drivers And Trends Drivers The rising prevalence of cancer is expected to propel the growth of the nivolumab market going forward. Trends Major Companies operating in the nivolumab market are focusing on developing innovative drugs to treat their customers and sustain their position in the market. Region North America was the largest region in the Nivolumab market in 2023. The regions covered in the Nivolumab market analysis report are Asia- Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. © The Business Research Company. All Rights Reserved.

  5. Top Eleven Players In The Market Major players in the market are: ▪ Sanofi S.A. ▪ Pfizer Inc. ▪ Bristol-Myers Squibb ▪ Johnson & Johnson Services Company Inc. ▪ AstraZeneca PLC ▪ F. Hoffmann-La Roche Ltd. ▪ GlaxoSmithKline PLC ▪ Merck & Co. Inc. ▪ Takeda Pharmaceutical ▪ AbbVie Inc. Company Limited ▪ Novartis AG Get More Information On The Market Report © The Business Research Company. All Rights Reserved.

  6. 7 Reasons Why TBRC Is The Solution You Need 1. Global Macroeconomic Impact: Assess global economic factors' influence on market growth. 2. Market Size Ratios: Explore market size, GDP proportions, and expenditure per capita. 3. Global Perspective: Reports cover 60 geographies for a comprehensive global understanding. 4. Localized Strategies: Create region-specific strategies aligning with market nuances. 5. Investment Insights: Identify growth segments through forecast data and market insights. 6. Competitor Benchmarking: Compare performance against key competitors. 7. Presentation Support: Reports offer reliable data for internal and external presentations. © The Business Research Company. All Rights Reserved.

  7. Americas The Business Research Company, 1295 N Providence Rd, Media, PA 19063, USA ✆ ✆ +1 3156230293 Get In Touch Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE How ever you want to grow and expand, The Business Research Company can help as we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. ✆ ✆ +44 207 1930 708 Asia The Business Research Company, 1st Floor, Anshu Colors Building, Road Number 1, Park View Enclave, Jubilee Hills, Hyderabad (India), 500033 info@tbrc.info ✆ ✆ +91 8897263534 @The Business Research Company. All rights reserved. © The Business Research Company. All Rights Reserved.

  8. Your Growth Insights Partner © The Business Research Company. All Rights Reserved.

More Related